ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) |
Grant Type |
Year | State |
|---|---|---|---|---|
| Single Cell Signaling Profiles In High-Risk Pediatric Leukemia | Stanford University / Kara Davis | Young Investigator Grants | 2010 | California |
| Elucidating the Roles of Aneuploidy in Down Syndrome-Associated Leukemia | Boston Children’s Hospital / Chun-Chin Chen, PhD | Young Investigator Grants | 2023 | Massachusetts |
| MYCN-induced molecular clock disruption and metabolic rewiring drive neuroblastoma | Baylor College of Medicine / Lingzhi Li, PhD | Young Investigator Grants | 2024 | Texas |
| MYC-driven Core Regulatory Circuits in Neuroblastoma | Dana-Farber Cancer Institute / Mark Zimmerman, PhD | Young Investigator Grants | 2018 | Massachusetts |
| CAMKV as a Target for Immunotherapy in MYCN-Amplified Neuroblastoma | Children’s Hospital of Philadelphia / Robyn Sussman, PhD | Young Investigator Grants | 2015 | Pennsylvania |
| The Role of PASG in Mediating Epigenetic Change and Outcome in AML. | The Johns Hopkins University School of Medicine / Jason Farrar, MD | Young Investigator Grants | 2007 | Maryland |
| Genomic Alterations in ETV6 Predict Outcome in Pediatric AML | Fred Hutchinson Cancer Research Center / Heather Helton, MD | Young Investigator Grants | 2013 | Washington |
| The Role of LIN28B-let-7-PBK Axis on the Growth and Metastasis of Group 3 Medulloblastoma | Emory University / Shubin Shahab, MD/PhD | Young Investigator Grants | 2021 | Georgia |
| Capitalizing on functional genomics with targeted protein degradation in neuroblastoma | St. Jude Children’s Research Hospital / Ian Delahunty, PhD | Young Investigator Grants | 2024 | Tennessee |
| Accessing Combinatorial Effect of PARP Inhibitor with DNA Damaging Agent in Rhabdomyosarcoma at Single Cell Resolution | Massachusetts General Hospital / Chuan Yan, PhD | Young Investigator Grants | 2018 | Massachusetts |